advertisement

Oculus

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (63)

Showing records 1 to 25

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Lajmi H
Journal of current ophthalmology 2021; 33: 128-135
94821 Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study
Gautam N
Current Eye Research 2021; 0: 1-9
94845 Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Seong HJ
Korean Journal of Ophthalmology 2021; 35: 235-241
94930 Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs
Youshia J
European Journal of Pharmaceutical Sciences 2021; 163: 105887
94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Denis P
European Journal of Ophthalmology 2021; 31: 1056-1063
94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Vincent MP
ACS applied materials & interfaces 2021; 13: 32823-32836
94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Lajmi H
Journal Franšais d'Ophtalmologie 2021; 0:
94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Sonntag T
Pharmaceutics 2021; 13:
94766 A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
Peter M
Advanced pharmaceutical bulletin 2021; 11: 399-413
94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Wang J
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425:
94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Aptel F
Journal of Glaucoma 2021; 30: 718-724
94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Jansook P
International Journal of Pharmaceutics 2021; 606: 120955
94845 Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Lee K
Korean Journal of Ophthalmology 2021; 35: 235-241
94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Froemel F
Pharmaceutics 2021; 13:
94766 A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
Panonnummal R
Advanced pharmaceutical bulletin 2021; 11: 399-413
94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Stack T
ACS applied materials & interfaces 2021; 13: 32823-32836
94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Hnin HM
International Journal of Pharmaceutics 2021; 606: 120955
94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Chelly Z
Journal Franšais d'Ophtalmologie 2021; 0:
94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Hmaied W
Journal of current ophthalmology 2021; 33: 128-135
94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Villemont AS
Journal of Glaucoma 2021; 30: 718-724
94821 Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study
Kesavan K
Current Eye Research 2021; 0: 1-9
94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Li B
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425:
94930 Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs
Kamel AO
European Journal of Pharmaceutical Sciences 2021; 163: 105887
94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Duch S
European Journal of Ophthalmology 2021; 31: 1056-1063
94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Cunnac P
Journal of Glaucoma 2021; 30: 718-724

Issue 22-2

Change Issue


advertisement

Oculus